Pretreatment Neutrophil-to-Lymphocyte Ratio Combined with Platelet-to-Lymphocyte Ratio as a Predictor of Survival Outcomes after Definitive Concurrent Chemoradiotherapy for Cervical Cancer.

J Clin Med · 2021 · PMC8160639 · PMID 34069592

Europe PMC DOI

hedged sentence

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

not quite significantp = 0.069so close (0.05 < p ≤ 0.1)

The presence of LN metastasis (HR 2.805; 95% CI, 1.359–5.792; p = 0.005) was the only independent predictor of DFS, and pretreatment NLR-PLR group was not quite significant ( p = 0.069).

also in 653 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.